Cargando…
A Korean Family of Familial Medullary Thyroid Cancer with Cys618Ser RET Germline Mutation
Familial medullary thyroid carcinoma (FMTC) is caused by autosomal dominant gain-of-function mutations in the RET proto-oncogene. An identifiable RET mutation can be detected in about 85% of FMTC families. The majority of germline mutations in FMTC have been found in exons 10 and 11 of the RET proto...
Autores principales: | Jung, Jinhyang, Uchino, Shinya, Lee, Youngha, Park, Hoyong |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811288/ https://www.ncbi.nlm.nih.gov/pubmed/20119574 http://dx.doi.org/10.3346/jkms.2010.25.2.226 |
Ejemplares similares
-
Clinical characteristics of a large familial cohort with Medullary thyroid cancer and germline Cys618Arg RET mutation in an Israeli multicenter study
por: Rosenblum, Rachel Chava, et al.
Publicado: (2023) -
RET codon 618 mutations in Saudi families with multiple endocrine neoplasia Type 2A and familial medullary thyroid carcinoma
por: Qari, Faiza
Publicado: (2013) -
A Case of Medullary Thyroid Carcinoma with de novo V804M RET Germline Mutation
por: Choi, Young Sik, et al.
Publicado: (2013) -
RET mutations in a large indian family with medullary thyroid carcinoma
por: Mahesh, D. M., et al.
Publicado: (2014) -
A Novel Somatic Mutation in the RET Proto‐oncogene in Familial Medullary Thyroid Carcinoma with a Germline Codon 768 Mutation
por: Miyauchi, Akira, et al.
Publicado: (1997)